Infection of neonatal swine with Clostridium difficile

Clostridium difficile is an established cause of antibiotic-associated diarrhea and pseudomembranous colitis in humans and domestic and laboratory animals. Diagnostic findings support a role for C. difficile in neonatal enteritis of pigs. A typical case will occur in a piglet 1–7 days of age, with diarrhea beginning soon after birth. Pathology includes moderate to severe mesocolonic edema, sometimes accompanied by hydrothorax and/or ascites, with scattered foci of suppuration in the colonic lamina propria and accumulation of neutrophils in the mesocolon. Exudation of neutrophils and fibrin into the lumen gives rise to socalled “volcano” lesions. Cultures of affected tissues commonly yield heavy growth of C. difficile, and toxin testing almost invariably reveals the presence of toxins A and B. Treatment with antimicrobials and use of probiotics has yielded mainly unsatisfactory results, but bacitracin methylene disalicylate may be useful for prevention. The lack of commercially available immunoprophylactic products may cause producers to turn to autogenous bacterin/toxoids, but their effectiveness is uncertain.

[1]  T. Monath,et al.  Serum Antitoxin Antibodies Mediate Systemic and Mucosal Protection from Clostridium difficileDisease in Hamsters , 1999, Infection and Immunity.

[2]  J. Kink,et al.  Antibodies to Recombinant Clostridium difficile Toxins A and B Are an Effective Treatment and Prevent Relapse of C. difficile-Associated Disease in a Hamster Model of Infection , 1998, Infection and Immunity.

[3]  S. Borriello,et al.  Pathogenesis of Clostridium difficile infection. , 1998, The Journal of antimicrobial chemotherapy.

[4]  E G Clark,et al.  Typhlocolitis Caused by Clostridium Difficile in Suckling Piglets , 1998, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[5]  J. Madigan,et al.  Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  T. Monath,et al.  Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters , 1995, Infection and immunity.

[7]  Smith Gd,et al.  Use of vancomycin hydrochloride for treatment of Clostridium difficile enteritis in Syrian hamsters. , 1994 .

[8]  C. Gries,et al.  Use of vancomycin hydrochloride for treatment of Clostridium difficile enteritis in Syrian hamsters. , 1994, Laboratory animal science.

[9]  L. J. McCutcheon,et al.  Use of bacitracin in the prevention and treatment of experimentally-induced idiopathic colitis in horses. , 1992, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[10]  L. Mcfarland,et al.  Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters , 1987, Antimicrobial Agents and Chemotherapy.

[11]  S. Borriello,et al.  Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains. , 1985, Journal of medical microbiology.

[12]  G. Elmer,et al.  Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii , 1984, Antimicrobial Agents and Chemotherapy.

[13]  M. A. Jones,et al.  Isolation of Clostridium difficile from pigs , 1983, Veterinary Record.

[14]  R. Lemcke,et al.  Studies of organisms possibly implicated in swine dysentery , 1980 .

[15]  H. Waskin,et al.  Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin , 1979 .